IPO News & Commentary
Get the latest insights on new stocks
- SPAC K2 Capital Acquisition prices upsized $120 million IPO, targeting robotics and nuclear energy 01/29/26
- Ethos Technologies prices IPO at $19, within the range 01/29/26
- Brazilian digital bank PicS prices US IPO at $19, the high end of the range 01/28/26
- Satellite manufacturer York Space Systems prices upsized IPO at $34, the high end of the range 01/28/26
- Malaysia-based business consulting firm V Capital Consulting Group files for a $15 million US IPO 01/28/26
- SPAC Sky Acquisition Group files for a $150 million IPO, targeting the AI industry 01/28/26
- Hong Kong-based Cafe Deco Group ups shares offered, decreases range ahead of $19 million US IPO 01/28/26
See more
IPO News By Industry
- Satellite manufacturer York Space Systems prices upsized IPO at $34, the high end of the range 01/28/26
- Malaysia-based business consulting firm V Capital Consulting Group files for a $15 million US IPO 01/28/26
- Singaporean consulting firm HAMA Intelligence nearly triples shares offered ahead of $18 million US IPO 01/28/26
- Chinese copper producer Xinxu Copper more than doubles size of proposed $17 million US IPO 01/26/26
- Uranium exploration company Jaguar Uranium ups shares offered by 50% ahead of $30 million US IPO 01/26/26
- US IPO Weekly Recap: Equipment rental rises while crypto company crashes in 2-IPO week 01/23/26
- Real estate consultant Lorenzo Developments more than triples shares offered ahead of $31 million US IPO 01/28/26
- Japan-based real estate company Nihon Shintatsu triples shares offered ahead of $19 million US IPO 01/15/26
- Hong Kong student dorm provider Student Living EduVation files for a $29 million US IPO 12/23/25
- Xsolla SPAC 1 prices downsized $200 million IPO, led by the founder of video game fintech Xsolla 01/29/26
- SPAC United Acquisition I prices $100 million IPO; led by Paul Packer, whose previous SPAC merged with Forafric 01/29/26
- SPAC K2 Capital Acquisition prices upsized $120 million IPO, targeting robotics and nuclear energy 01/29/26
NYSE IPO News
- Satellite manufacturer York Space Systems prices upsized IPO at $34, the high end of the range 01/28/26
- Hair loss biotech Veradermics sets terms for $200 million IPO 01/28/26
- Electrical equipment maker Forgent Power Solutions sets terms for $1.5 billion IPO 01/26/26
- Jennifer Garner's baby food brand Once Upon a Farm sets terms for $198 million IPO 01/26/26
- Budget furniture retailer Bob's Discount Furniture sets terms for $350 million IPO 01/26/26
Nasdaq IPO News
- Xsolla SPAC 1 prices downsized $200 million IPO, led by the founder of video game fintech Xsolla 01/29/26
- Belgian fibrotic disease biotech AgomAb Therapeutics sets terms for $200 million US IPO 01/29/26
- SPAC K2 Capital Acquisition prices upsized $120 million IPO, targeting robotics and nuclear energy 01/29/26
- Ethos Technologies prices IPO at $19, within the range 01/29/26
- Brazilian digital bank PicS prices US IPO at $19, the high end of the range 01/28/26
Be the in-house IPO Expert
Our clients are focused on catalyzing growth and creating value.
Not scouring the web for IPO data.
Get the information you need in minutes, not hours. With IPO Pro, you have the entire US IPO market at your fingertips.
Xsolla SPAC 1 prices downsized $200 million IPO, led by the founder of video game fintech Xsolla
Xsolla SPAC 1, a blank check company led by executives from video game fintech Xsolla, raised $200 million by offering 20 million units at $10. Each unit consists of one share of common stock and one-half of one warrant exercisable at $11.50 per share. The ...read more
SPAC United Acquisition I prices $100 million IPO; led by Paul Packer, whose previous SPAC merged with Forafric
United Acquisition I, a blank check company led by Globis Capital Advisors founder Paul Packer, raised $100 million by offering 10 million units at $10. Each unit consists of one ordinary share and one-quarter of one warrant, exercisable at $11.50 per...read more
Belgian fibrotic disease biotech AgomAb Therapeutics sets terms for $200 million US IPO
AgomAb Therapeutics, a Belgian Phase 2 biotech developing TGFβ inhibitors for Crohn's and other fibrotic diseases, announced terms for its IPO on Thursday. The Antwerp, Belgium-based company plans to raise $200 million by offering 12.5 million shares at a ...read more